Not a Vision. A Portfolio. European API Production, Already Happening.

Others Talk – We Are Bringing Production Back to Europe

Under the leadership of our CSO Henriette, we have built an incredible portfolio of Active Pharmaceutical Ingredients (APIs) and already started 𝗯𝗿𝗶𝗻𝗴𝗶𝗻𝗴 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻 𝗯𝗮𝗰𝗸 — 𝗰𝗼𝘀𝘁-𝗰𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲, 𝗿𝗲𝘀𝗶𝗹𝗶𝗲𝗻𝘁, 𝗮𝗻𝗱 𝗴𝗿𝗲𝗲𝗻𝗲𝗿 𝗯𝘆 𝗱𝗲𝘀𝗶𝗴𝗻.

Our portfolio represents molecules where we can:

• Re-establish European production with 𝗾𝘂𝗮𝗹𝗶𝗳𝗶𝗲𝗱 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀
• Achieve 𝗰𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗲𝗰𝗼𝗻𝗼𝗺𝗶𝗰𝘀
• Reduce dependency on 𝘀𝗶𝗻𝗴𝗹𝗲-𝗿𝗲𝗴𝗶𝗼𝗻 𝘀𝘂𝗽𝗽𝗹𝘆 𝗰𝗵𝗮𝗶𝗻𝘀
• Implement 𝗴𝗿𝗲𝗲𝗻𝗲𝗿 𝗽𝗿𝗼𝗰𝗲𝘀𝘀 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀 𝗳𝗿𝗼𝗺 𝗱𝗮𝘆 𝗼𝗻𝗲
• Secure 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆-𝗿𝗲𝗮𝗱𝘆, 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝗶𝗮𝗹-𝘀𝗰𝗮𝗹𝗲 𝗽𝗮𝘁𝗵𝘄𝗮𝘆𝘀

Is something missing in our portfolio?

Let’s talk. We enable 𝗹𝗼𝗰𝗮𝗹 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻, 𝗿𝗲𝘀𝗶𝗹𝗶𝗲𝗻𝘁 𝘀𝘂𝗽𝗽𝗹𝘆 𝗰𝗵𝗮𝗶𝗻𝘀, and 𝗰𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 — we are here to support you.

For pharma companies, this means:

·     Lower geopolitical exposure
·      Industrial reliability at competitive pricing
·      Greater transparency in sourcing
·      Stronger ESG positioning
·      A green premium without added costs

“I am so proud of what the team has achieved. 𝗘𝘂𝗿𝗼𝗽𝗲 𝗱𝗼𝗲𝘀 𝗻𝗼𝘁 𝗹𝗮𝗰𝗸 𝗰𝗮𝗽𝗮𝗯𝗶𝗹𝗶𝘁𝘆 — 𝗶𝘁 𝗻𝗲𝗲𝗱𝘀 𝗲𝘅𝗲𝗰𝘂𝘁𝗶𝗼𝗻. We are ready to execute.”

Dr. Henriette Nowothnick, our Co-Founder and CSO.